These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8640873

  • 1. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
    Yaron I, Yaron R, Oluwole SF, Hardy MA.
    Cell Immunol; 1996 Mar 15; 168(2):258-66. PubMed ID: 8640873
    [Abstract] [Full Text] [Related]

  • 2. The mechanism of UVB prevention of graft versus host disease.
    Greenfeld JI, Chabot JA, Oluwole SF, Hardy MA.
    J Surg Res; 1996 Jan 15; 60(1):137-41. PubMed ID: 8592404
    [Abstract] [Full Text] [Related]

  • 3. Effects of ultraviolet-B irradiation on human LAK and NK cytotoxic activity.
    Yaron I, Zakheim AR, Oluwole SF, Hardy MA.
    Cell Immunol; 1995 Oct 15; 165(2):168-76. PubMed ID: 7553880
    [Abstract] [Full Text] [Related]

  • 4. UVB-irradiation of human bone marrow: potential for donor specific tolerance.
    Noizat-Pirenne F, Greenfeld JI, Hardy MA, Oluwole SF, De Groote D, Franchimont P.
    J Surg Res; 1996 Feb 15; 61(1):267-74. PubMed ID: 8769977
    [Abstract] [Full Text] [Related]

  • 5. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE.
    J Immunol; 1999 Nov 01; 163(9):5145-56. PubMed ID: 10528221
    [Abstract] [Full Text] [Related]

  • 6. The direct pathway of human T-Cell allorecognition is not tolerized by stimulation with allogeneic peripheral blood mononuclear cells irradiated with high-dose ultraviolet B.
    Wallgren AC, Alder J, Andersson B, Karlsson-Parra A, Bäcker AE.
    Scand J Immunol; 2006 Feb 01; 63(2):90-6. PubMed ID: 16476007
    [Abstract] [Full Text] [Related]

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 8. In vitro immunosuppressive effect: a comparative study between deoxymethylspergualin and cyclosporin A, on human lymphocyte responses.
    Jiang H, Takahara S, Kokado Y, Ishibashi M, Sonoda T.
    J Clin Lab Immunol; 1990 Oct 01; 33(2):75-81. PubMed ID: 1967069
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells.
    Nikolaeva N, Bemelman FJ, Yong SL, van Lier RA, ten Berge IJ.
    Transplantation; 2006 Feb 15; 81(3):445-54. PubMed ID: 16477233
    [Abstract] [Full Text] [Related]

  • 10. In vitro effects of ultraviolet B radiation on human Langerhans cell antigen-presenting function.
    Rattis FM, Péguet-Navarro J, Courtellemont P, Redziniak G, Schmitt D.
    Cell Immunol; 1995 Aug 15; 164(1):65-72. PubMed ID: 7634352
    [Abstract] [Full Text] [Related]

  • 11. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ, Michielsen EC, Verstappen J, Fasse E, Joosten I.
    Transplantation; 2003 May 15; 75(9):1581-90. PubMed ID: 12792519
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation.
    Waer M, Vanrenterghem Y, Ang KK, Van der Schueren E, Michielsen P, Vandeputte M.
    J Immunol; 1984 Feb 15; 132(2):1041-8. PubMed ID: 6228588
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
    Botzler C, Kis K, Issels R, Multhoff G.
    Exp Hematol; 1997 Apr 15; 25(4):338-44. PubMed ID: 9131009
    [Abstract] [Full Text] [Related]

  • 14. Ultraviolet-B irradiation of leukapheresis. Products: dose-response relationship with the mixed lymphocyte reaction.
    Foster PF, Gebel H, McLeod BC, Ebert N, Jensik S, Sankary HN, Tambur A, Williams JW.
    J Clin Apher; 1996 Apr 15; 11(2):55-60. PubMed ID: 8844433
    [Abstract] [Full Text] [Related]

  • 15. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Vallera DA.
    J Immunol; 1998 Jun 01; 160(11):5355-65. PubMed ID: 9605135
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD, Lerner CG, Schwartz RH.
    J Immunol; 1999 Mar 01; 162(5):2775-84. PubMed ID: 10072524
    [Abstract] [Full Text] [Related]

  • 17. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2003 Jul 15; 76(1):216-24. PubMed ID: 12865813
    [Abstract] [Full Text] [Related]

  • 18. UV irradiation of lymphocytes triggers an increase in intracellular Ca2+ and prevents lectin-stimulated Ca2+ mobilization: evidence for UV- and nifedipine-sensitive Ca2+ channels.
    Spielberg H, June CH, Blair OC, Nystrom-Rosander C, Cereb N, Deeg HJ.
    Exp Hematol; 1991 Sep 15; 19(8):742-8. PubMed ID: 1651252
    [Abstract] [Full Text] [Related]

  • 19. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW, Hara H, Tesmann JP, Martin S, Simon JC.
    J Leukoc Biol; 2001 Apr 15; 69(4):548-54. PubMed ID: 11310840
    [Abstract] [Full Text] [Related]

  • 20. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W, Yang Y, Zhang F, Li YC, Zhou R, Wang JX, Zhu YN, Li XY, Yang YF, Zuo JP.
    Int Immunopharmacol; 2005 Dec 15; 5(13-14):1904-13. PubMed ID: 16275625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.